| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0889-857X(05)70304-5 |
| P698 | PubMed publication ID | 8923599 |
| P2093 | author name string | Deswal A | |
| Follansbee WP | |||
| P2860 | cites work | Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | Q28300531 |
| The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). | Q33173262 | ||
| The toxicity of D-penicillamine in systemic sclerosis | Q33444614 | ||
| Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma | Q33556913 | ||
| The heart in scleroderma | Q33599610 | ||
| Skeletal muscle involvement in systemic sclerosis | Q33626792 | ||
| D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis | Q34057018 | ||
| Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis | Q36061884 | ||
| Temporal evolution of changes in left ventricular function induced by cold pressor stimulation. An assessment with radionuclide angiography and gold 195m | Q36749852 | ||
| Pericardial tamponade in systemic sclerosis (scleroderma) | Q36767316 | ||
| Treatment of scleroderma heart by D-penicillamine | Q36796260 | ||
| Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma) | Q39216663 | ||
| Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor | Q39343520 | ||
| Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. | Q39367451 | ||
| The electrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature | Q39614635 | ||
| Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature | Q39794476 | ||
| Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies | Q39876536 | ||
| Echocardiographic identification of cardiac abnormality in scleroderma and related disorders | Q39881729 | ||
| Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features. | Q40277930 | ||
| Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine | Q40339419 | ||
| Association of myositis and myocarditis in progressive systemic sclerosis | Q40351861 | ||
| Pericardial disease in scleroderma (systemic sclerosis). | Q40902216 | ||
| Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients | Q41271611 | ||
| Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction | Q44007356 | ||
| Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis | Q44747538 | ||
| Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients | Q45337964 | ||
| A Semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis | Q46193205 | ||
| Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls | Q49051672 | ||
| Decreased coronary reserve in primary scleroderma myocardial disease. | Q54448999 | ||
| International study of ketanserin in Raynaud's phenomenon | Q57403454 | ||
| Hypertrophic nonobstructive cardiomyopathy in scleroderma | Q66840281 | ||
| Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: A clinicopathologic study of 9 patients with progressive systemic sclerosis | Q67314586 | ||
| Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients | Q68109540 | ||
| Frequency of late potentials in systemic sclerosis | Q68204154 | ||
| Prognostic importance of cardiac arrhythmias in systemic sclerosis | Q68385979 | ||
| The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis | Q68504755 | ||
| Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis | Q68797448 | ||
| The cardiovascular manifestations of systemic sclerosis (scleroderma) | Q68799968 | ||
| Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis | Q68893602 | ||
| Cyclosporin A in progressive systemic sclerosis | Q69189128 | ||
| Cold-induced reversible myocardial ischaemia in systemic sclerosis | Q69373238 | ||
| Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study | Q69502083 | ||
| Reversible myocardial perfusion defects during cold challenge in scleroderma | Q69507773 | ||
| Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis | Q69634697 | ||
| Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma | Q69740792 | ||
| Cardiac involvement in systemic sclerosis | Q69797094 | ||
| Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease | Q69940844 | ||
| Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis | Q70024499 | ||
| Clinical course of patients with scleroderma renal crisis treated with captopril | Q70170375 | ||
| Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma | Q70232445 | ||
| A Double-blind Study of Prazosin in the Treatment of Raynaud's Phenomenon in Scleroderma | Q70330332 | ||
| The heart in scleroderma: noninvasive assessment | Q70425240 | ||
| Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association | Q70523026 | ||
| Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma | Q70606919 | ||
| Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma | Q70695952 | ||
| Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders | Q71154365 | ||
| Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma | Q71252764 | ||
| The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis | Q71427003 | ||
| Plasmapheresis and immunosuppressive drug therapy in scleroderma | Q72098186 | ||
| Skeletal muscle involvement in progressive systemic sclerosis (scleroderma) | Q72104767 | ||
| Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis | Q72331665 | ||
| Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma | Q72664368 | ||
| Cardiovascular function in patients with progressive systemic sclerosis (scleroderma) | Q72771666 | ||
| The heart in scleroderma | Q72827316 | ||
| Scleroderma; based on a study of over 150 cases | Q73642800 | ||
| Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients | Q93644161 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 841-860 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Rheumatic Diseases Clinics of North America | Q7320483 |
| P1476 | title | Cardiac involvement in scleroderma | |
| P478 | volume | 22 |
| Q64377269 | Acute myocarditis associated with adenoviral infection in a patient with scleroderma |
| Q52950743 | Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis. |
| Q35799365 | Avian models with spontaneous autoimmune diseases |
| Q56978245 | Bosentan for the treatment of scleroderma |
| Q92750035 | CMR feature tracking in cardiac asymptomatic systemic sclerosis: Clinical implications |
| Q34981326 | Cardiac involvement in systemic autoimmune diseases |
| Q33160288 | Cardiac involvement in systemic sclerosis |
| Q39036353 | Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature. |
| Q77670948 | Cardiovascular Complications of Collagen Vascular Disease |
| Q77903321 | Cardiovascular manifestations of systemic autoimmune diseases |
| Q37720766 | Case 3: - congestive heart failure in male with systemic sclerosis |
| Q41789551 | Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension |
| Q51327469 | Complete heart block in a patient with systemic sclerosis. |
| Q48265042 | Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic scl |
| Q37702640 | Echocardiographic follow-up of patients with systemic sclerosis by 2D speckle tracking echocardiography of the left ventricle |
| Q42955864 | Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis |
| Q36283456 | Heart involvement and systemic sclerosis. |
| Q30500539 | Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study |
| Q46748665 | Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases |
| Q42475025 | Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis |
| Q48283702 | Left atrial phasic function and heart rate variability in patients with systemic sclerosis: A new part of the old puzzle. |
| Q48526663 | Mechanics and prognostic value of left and right ventricular dysfunction in patients with systemic sclerosis |
| Q88035087 | Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance |
| Q48530798 | New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction. |
| Q73034479 | Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis |
| Q36426529 | Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. |
| Q30453741 | Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests |
| Q36426633 | Right ventricular thickness as predictor of global myocardial performance in systemic sclerosis: A Doppler tissue imaging study |
| Q34816370 | SLE with recurrent heart failure and a dermatological clue to another added possibility |
| Q33909729 | Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. |
| Q51755872 | Systemic sclerosis sine scleroderma associated with Wolff-Parkinson-White syndrome. |
| Q80842711 | The heart in scleroderma |
| Q52971055 | The possible role of myocardial biopsy in systemic sclerosis. |
| Q35517421 | The right ventricle in scleroderma (2013 Grover Conference Series). |
| Q73353348 | [Detection of coronary cold induced ischaemia by cardiac SPECT with 99mTc-tetrofosmin in a patient with limited scleroderma] |
| Q74521081 | [Pathology of diseases of extracardiac origin. VI. Disease of the connective tissue and heart] |
Search more.